Skip to content
FY'25FY'24FY'23FY'22
Profitability
Gross margin77.2%-0.9pp78.1%-1.1pp79.2%-1.8pp80.9%-0.9pp
Operating margin24%-2.7pp26.7%-6.3pp33%+5.5pp27.4%-1.2pp
Net margin18.3%-2.1pp20.4%-1.8pp22.1%-19.3pp41.4%+30.1pp
Returns
Return on equity20.8%-5.1pp25.8%-3.8pp29.6%-32.0pp61.6%+37.2pp
Return on invested capital45.6%+6.4pp39.2%-1.3pp40.5%-7.5pp48%-28.8pp
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.8×0.0×0.8×+0.1×
Liquidity
Current ratio3.6×+0.3×3.3×+0.6×2.8×-2.3×5.1×-0.2×
Leverage
Debt-to-equity0.2×-0.1×0.3×-0.1×0.4×-0.1×0.5×-0.6×
Net debt / EBITDA-2.5×-1.2×-1.3×-0.7×-0.5×-0.2×-0.3×0.0×
Per Share
Book value per share$14.86+30.5%$11.39+47.3%$7.74+17.3%$6.59+109%
Valuation
Market capitalization$2.16B+9.8%$1.96B+4.2%$1.88B-42.5%$3.28B+30.5%
Price / earnings13.6×+0.1×13.5×-1.1×14.6×-3.4×18.1×-54.5×
Price / sales2.5×-0.3×2.7×-0.5×3.2×-4.2×7.5×-0.7×
Price / book2.5×-0.5×-1.1×-4.1×8.1×-5.3×
EV / EBITDA6.8×-1.1×7.9×-0.3×8.2×-14.3×22.5×-0.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?
Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.
Where do Harmony Biosciences Holdings, Inc.'s ratios come from?
Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.